|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Bio-active compounds are of high aesthetic value in pharmaceutical industries but they are not widely explored. These compounds derived from plant, fungi and bacteria cannot really satisfy even a small fraction of the existing demand of the growing population day by day. In recent years, there is a great deal of attention towards cyanobacteria as they are a vast reserve of bioactive molecules with wide pharmaceutical importance. Extremophiles cyanobacteria have the ability to endure extreme conditions and posses a great capacity for producing biologically active compounds that are capable of meeting the global demand as an alternative source of drugs with economic sustainability. Thus, approaches for making extremophiles cyanobacteria as therapeutic agents specifically focused on antimicrobial activities can hold a scintillating future in scientific research to get invested in the field of pharmaceuticals as well as for industrial applications.